Tuesday June 16, 2020 – A giant pharmaceutical firm in United Kingdom has already begun human trials for a vaccine developed by the University of Oxford

AstraZeneca’s potential coronavirus vaccine is likely to provide protection against contracting Covid19 for about a year, the company’s Chief Executive Officer, Pascal Soriot, told a Belgian radio station on Tuesday.

The giant pharma has already begun human trials of the vaccine developed by the University of Oxford, with phase I trial in Britain due to end soon and phase III trial already begun.

“We think that it will protect for about a year,” Soriot said.

“If all goes well, we will have the results of the clinical trials in August/ September.”

“We are manufacturing in parallel.”

“We will be ready to deliver from October if all goes well,” Soriot added.

AstraZeneca said on Saturday that it had signed contracts with France, Germany, Italy and the Netherlands to supply the European Union with up to 400 million doses of the potential vaccine.

The United States Government has also signed a deal with the big pharma to supply millions of doses.

The Kenyan DAILY POST


Leave a Reply